165 filings
Page 4 of 9
8-K
nxsxy997 lvj7d3c0
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
xsyjvt
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am
8-K
pjybz0xf7ehoelm69
28 Jan 21
Other Events
8:11am
8-K
lg6v0bz
27 Jan 21
Other Events
4:11pm
8-K
04v 5ymis7sstih9
12 Nov 20
PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
4:12pm
8-K
8gz87 y6bt2ltco6ls
23 Oct 20
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:20am
8-K
ip4vipi4t60nw3lv3d
6 Oct 20
Other Events
8:09am
8-K
qpfsbjcu xqoycdn
11 Aug 20
PhaseBio Reports Recent Business Highlights and Second-Quarter 2020 Financial Results
4:09pm
8-K
8ooigkzgxg x9mm
16 Jul 20
Other Events
4:10pm
8-K
pf6y7r
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:36pm
8-K
9j4nf7g9 ej7
27 May 20
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
4:11pm
8-K
ojazclljfd
12 May 20
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
4:08pm
S-8
nobnenti84
30 Mar 20
Registration of securities for employees
8:29am
8-K
krrcrst 94wphr2m
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am